Solvay Chemicals, Inc.

Solvay is a multi-specialty chemical company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers in diverse global end markets. Its products and solutions are used in planes, cars, smart and medical devices, batteries, in mineral and oil extraction, among many other applications promoting sustainability. Its lightweighting materials enhance cleaner mobility, its formulations optimize the use of resources and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 27,000 employees in 58 countries. Net sales were € 10.9 billion in 2016, with 90% from activities where Solvay ranks among the world’s top 3 leaders. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris (Bloomberg: SOLB.BB - Reuters: SOLB.BR) and in the United States its shares (SOLVY) are traded through a level-1 ADR program.

Company details

3737 Buffalo Speedway, Suite 800 , Houston , Texas 77098 USA

More Office Locations Locations Served

Business Type:
Industry Type:
Chemical & Pharmaceuticals
Market Focus:
Globally (various continents)


Our companyAsking more from chemistry for 150 year

Created in 1863, Solvay is a global company driven by proud and committed chemists. With our historical anchorage in Europe, our products serve diversified markets worldwide, from consumer goods to energy, with one main aim – to improve quality of life and customer performance. 

The drive to achieve our aim has resulted in 90 percent of our revenue being generated from businesses that are among the top three global leaders in their field.

We want to find answers and respond to the challenges of 3 major megatrends: evolving demography and consumer behavior, innovation acceleration, resource constraints and demand for sustainability.
Our strategy is to participate in reshaping the global chemical industry and to build a model of chemistry that will address these crucial issues while continuing to drive value creation and profitable growth. 

We reach this through:

  • a permanent reshaping of our portfolio
  • the strengthening of our growth engines
  • the acceleration of our organic growth, innovation, and acquisitions


Solvay Chemicals, Inc. and its subsidiary Solvay Fluorides, LLC, are part of the Solvay Group, the leading global producer of hydrogen peroxide, soda ash, sodium bicarbonate, and sodium percarbonate. In markets ranging from alternative energy, automotive, pharmaceuticals, pulp & paper and many others, Solvay Chemicals delivers its customers in North America one of the broadest and deepest product portfolios available.

Headquartered in Houston, Solvay Chemicals has seven manufacturing and multiple distribution sites serving the region. From these locations, the company supports its chemicals, fluorides and SOLVAir businesses. A Responsible Care company, Solvay Chemicals and its businesses are dedicated to continuing the legacy of founder Ernest Solvay by developing, manufacturing and marketing products and solutions that will help meet the sustainable challenges of the present and future.

Solvay has been adapting to an ever-changing World for more than a Century and a half. It had to reinvent itself many times, always building on a strong heritage of social responsibility, technical excellence and a family character.
The company was born in 1863 out of a technological breakthrough, the ammonia-soda process set up by Ernest Solvay and a small circle of relatives including his brother Alfred. 
After difficult years of technical uncertainties, Solvay embarked on a rapid international expansion, building plants in the whole industrialized world.
In 1900, 95% of the soda ash consumed in the World were produced using the Solvay process.
The Group survived both World Wars, thanks to its family shareholder base and jealously guarded manufacturing secrets. And by the early 1950s, Solvay diversified and resumed its global expansion. 
The recent years witnessed other radical transformations, from the divestment of the pharmaceutical pillar to the acquisition of Rhodia and the creation of a new Solvay.